Robert Goeltz
Director Financiero/CFO en ARCUS BIOSCIENCES, INC. .
Fortuna: 227 667 $ al 30/04/2024
Cargos activos de Robert Goeltz
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ARCUS BIOSCIENCES, INC. | Director Financiero/CFO | 01/08/2020 | - |
| Comptroller/Controller/Auditor | 01/08/2020 | 09/03/2023 |
Historial de carrera de Robert Goeltz
Antiguos cargos conocidos de Robert Goeltz.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Director Financiero/CFO | 01/09/2017 | 01/08/2020 |
| CYTOMX THERAPEUTICS, INC. | Director Financiero/CFO | 27/05/2015 | 15/05/2017 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Director Financiero/CFO | 01/10/2013 | 01/05/2015 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Director Financiero/CFO | 01/07/2002 | 01/08/2004 |
Formación de Robert Goeltz.
| UCLA Anderson School of Management | Masters Business Admin |
| Goizueta Business School-Emory | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 8 |
Operativa
| Director of Finance/CFO | 5 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Robert Goeltz
- Experiencia
